Back to Search Start Over

Novelty-Related fMRI Responses of Precuneus and Medial Temporal Regions in Individuals at Risk for Alzheimer Disease

Authors :
Billette, Ornella V
Ziegler, Gabriel
Dahmen, Philip
Dechent, Peter
Dobisch, Laura
Fliessbach, Klaus
Freiesleben, Silka Dawn
Glanz, Wenzel
Göerß, Doreen
Haynes, John Dylan
Heneka, Michael T
Kilimann, Ingo
Aruci, Merita
Kimmich, Okka
Kleineidam, Luca
Laske, Christoph
Lohse, Andrea
Rostamzadeh, Ayda
Metzger, Coraline
Munk, Matthias H
Peters, Oliver
Preis, Lukas
Priller, Josef
Schütze, Hartmut
Scheffler, Klaus
Schneider, Anja
Spottke, Annika
Spruth, Eike Jakob
Ramirez, Alfredo
Röske, Sandra
Roy, Nina
Teipel, Stefan
Wagner, Michael
Wiltfang, Jens
Kizilirmak, Jasmin M
Wolfsgruber, Steffen
Yakupov, Renat
Zeidman, Peter
Jessen, Frank
Schott, Björn
Düzel, Emrah
Maass, Anne
Group, DELCODE Study
Richter, Anni
Altenstein, Slawek
Bartels, Claudia
Brosseron, Frederic
Cardenas-Blanco, Arturo
Source :
Neurology 99(8), e775-e788 (2022). doi:10.1212/WNL.0000000000200667, Neurology, 2022, ' Novelty-Related fMRI Responses of Precuneus and Medial Temporal Regions in Individuals at Risk for Alzheimer Disease ', Neurology, vol. 99, no. 8, pp. e775-e788 . https://doi.org/10.1212/WNL.0000000000200667
Publication Year :
2022
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2022.

Abstract

Background and ObjectivesWe assessed whether novelty-related fMRI activity in medial temporal lobe regions and the precuneus follows an inverted U-shaped pattern across the clinical spectrum of increased Alzheimer disease (AD) risk as previously suggested. Specifically, we tested for potentially increased activity in individuals with a higher AD risk due to subjective cognitive decline (SCD) or mild cognitive impairment (MCI). We further tested whether activity differences related to diagnostic groups were accounted for by CSF markers of AD or brain atrophy.MethodsWe studied 499 participants aged 60–88 years from the German Center for Neurodegenerative Diseases Longitudinal Cognitive Impairment and Dementia Study (DELCODE) who underwent task-fMRI. Participants included 163 cognitively normal (healthy control, HC) individuals, 222 SCD, 82 MCI, and 32 patients with clinical diagnosis of mild AD. CSF levels of β-amyloid 42/40 ratio and phosphorylated-tau181 were available from 232 participants. We used region-based analyses to assess novelty-related activity (novel > highly familiar scenes) in entorhinal cortex, hippocampus, and precuneus as well as whole-brain voxel-wise analyses. First, general linear models tested differences in fMRI activity between participant groups. Complementary regression models tested quadratic relationships between memory impairment and activity. Second, relationships of activity with AD CSF biomarkers and brain volume were analyzed. Analyses were controlled for age, sex, study site, and education.ResultsIn the precuneus, we observed an inverted U-shaped pattern of novelty-related activity across groups, with higher activity in SCD and MCI compared with HC, but not in patients with AD who showed relatively lower activity than MCI. This nonlinear pattern was confirmed by a quadratic relationship between memory impairment and precuneus activity. Precuneus activity was not related to AD biomarkers or brain volume. In contrast to the precuneus, hippocampal activity was reduced in AD dementia compared with all other groups and related to AD biomarkers.DiscussionNovelty-related activity in the precuneus follows a nonlinear pattern across the clinical spectrum of increased AD risk. Although the underlying mechanism remains unclear, increased precuneus activity might represent an early signature of memory impairment. Our results highlight the nonlinearity of activity alterations that should be considered in clinical trials using functional outcome measures or targeting hyperactivity.

Details

ISSN :
1526632X and 00283878
Volume :
99
Database :
OpenAIRE
Journal :
Neurology
Accession number :
edsair.doi.dedup.....3e48e3be90619f272c72d3aedf09be12
Full Text :
https://doi.org/10.1212/wnl.0000000000200667